LUNG NON-SMALL CELL SQUAMOUS CARCINOMA

Clinical trials for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LUNG NON-SMALL CELL SQUAMOUS CARCINOMA trials appear

Sign up with your email to follow new studies for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

Major trial aims to stop lung Cancer's return after surgery

Disease control Recruiting now

This large, late-stage trial is testing if adding an immunotherapy drug (pembrolizumab) to standard chemotherapy helps patients live longer without their cancer returning. It is for people with stage II or III non-small cell lung cancer who have already had their tumor surgically…

Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

LUNG NON-SMALL CELL SQUAMOUS CARCINOMA

Get alerted when new LUNG NON-SMALL CELL SQUAMOUS CARCINOMA trials appear

Major trial aims to stop lung Cancer's return after surgery